International guidelines recommend germline genetic testing for men with metastatic prostate cancer. If offered to all patients by genetic healthcare professionals, there will be insufficient capacity ...
Daily Mail on MSN
New prostate cancer test detects more dangerous tumours than standard PSA screening, study finds
A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.
The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from 14 presentations at AUA 2024, the annual meeting of ...
The Decipher Prostate Metastatic test is now available for metastatic prostate cancer, covered by Medicare for all risk levels. It helps clinicians determine which patients may benefit from treatment, ...
The media frenzy surrounding former President Joe Biden’s metastatic prostate cancer diagnosis last May didn’t faze one Lancaster resident. Doctors and politicians debated whether Biden and his ...
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use Tempus AI, Inc., a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results